HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Arrival of Imidazo[2,1-b]thiazole-5-carboxamides: Potent Anti-tuberculosis Agents That Target QcrB.

Abstract
Increasing interest in the potent anti-tuberculosis activity and the novel target (QcrB) of imidazo[1,2-a]pyridine-3-carboxamides encouraged extended structure-activity relationship studies of additional scaffolds. This study reports on the in vitro profiling of the imidazo[2,1-b]thiazole-5-carboxamides as a new promising class of anti-tuberculosis compounds endowed with nanomolar potency against replicating and drug-resistant Mycobacterium tuberculosis (Mtb) as well as low toxicity to VERO cells. Compounds 6, 16, and 17 had MIC values <10 nM and toxicity >100 μM. On-target selectivity of this series was confirmed by cross-resistance of specific QcrB mutants as well as the hypersusceptibility of a mutant with a functional gene deletion of the alternative cytochrome bd oxidase. Additionally, to demonstrate selectivity, three analogues (6, 15, 17) were broadly screened against a diverse set of eight strains of bacteria, including both Gram-positive and Gram-negative as well as six disease-causing non-tuberculosis mycobacteria. Finally, compounds 16 and 17 were found to be active in macrophages infected with Mtb.
AuthorsGarrett C Moraski, Natalie Seeger, Patricia A Miller, Allen G Oliver, Helena I Boshoff, Sanghyun Cho, Surafel Mulugeta, Jeffery R Anderson, Scott G Franzblau, Marvin J Miller
JournalACS infectious diseases (ACS Infect Dis) Vol. 2 Issue 6 Pg. 393-8 (06 10 2016) ISSN: 2373-8227 [Electronic] United States
PMID27627627 (Publication Type: Journal Article)
Chemical References
  • Antitubercular Agents
  • Imidazoles
  • Thiazoles
Topics
  • Animals
  • Antitubercular Agents (chemical synthesis, chemistry, pharmacology)
  • Chlorocebus aethiops
  • Humans
  • Imidazoles (chemistry)
  • Molecular Structure
  • Mycobacterium tuberculosis (drug effects, genetics, physiology)
  • Structure-Activity Relationship
  • Thiazoles (chemistry)
  • Tuberculosis (drug therapy, microbiology)
  • Vero Cells

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: